Eye Teaming Evaluation Study

This study has been completed.
Sponsor:
Information provided by:
Ohio State University
ClinicalTrials.gov Identifier:
NCT00472407
First received: May 9, 2007
Last updated: July 1, 2008
Last verified: July 2008
  Purpose

Measurement of near point of convergence (NPC) is often critical to the diagnosis of CI. This study will evaluate NPC measurements with commonly used target types.


Condition Intervention
Convergence Insufficiency
Device: NPC targets

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Open Label

Resource links provided by NLM:


Further study details as provided by Ohio State University:

Estimated Enrollment: 72
  Eligibility

Ages Eligible for Study:   9 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Ages of 9 to 30
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00472407

Locations
United States, Ohio
The Ohio State University College of Optometry
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Ohio State University
Investigators
Principal Investigator: Marjean Kulp, OD, MS Ohio State University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00472407     History of Changes
Other Study ID Numbers: 2004H0161
Study First Received: May 9, 2007
Last Updated: July 1, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Ohio State University:
Normal

Additional relevant MeSH terms:
Ocular Motility Disorders
Central Nervous System Diseases
Nervous System Diseases
Cranial Nerve Diseases
Eye Diseases

ClinicalTrials.gov processed this record on September 22, 2014